JPMorgan Chase & Co’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-9,197
| Closed | -$15K | – | 6218 |
|
|
2022
Q1 | $15K | Buy |
9,197
+1,648
| +22% | +$2.69K | ﹤0.01% | 5322 |
|
|
2021
Q4 | $18K | Sell |
7,549
-2,991
| -28% | -$7.13K | ﹤0.01% | 5355 |
|
|
2021
Q3 | $58K | Buy |
10,540
+992
| +10% | +$5.46K | ﹤0.01% | 4912 |
|
|
2021
Q2 | $71K | Buy |
9,548
+4,136
| +76% | +$30.8K | ﹤0.01% | 4861 |
|
|
2021
Q1 | $44K | Sell |
5,412
-2,702
| -33% | -$22K | ﹤0.01% | 4822 |
|
|
2020
Q4 | $73K | Buy |
8,114
+3,778
| +87% | +$34K | ﹤0.01% | 4367 |
|
|
2020
Q3 | $44K | Buy |
4,336
+985
| +29% | +$10K | ﹤0.01% | 4325 |
|
|
2020
Q2 | $25K | Sell |
3,351
-292
| -8% | -$2.18K | ﹤0.01% | 4379 |
|
|
2020
Q1 | $22K | Sell |
3,643
-64
| -2% | -$386 | ﹤0.01% | 4334 |
|
|
2019
Q4 | $19K | Buy |
3,707
+2,053
| +124% | +$10.5K | ﹤0.01% | 4430 |
|
|
2019
Q3 | $12K | Buy |
1,654
+268
| +19% | +$1.94K | ﹤0.01% | 4556 |
|
|
2019
Q2 | $16K | Buy |
1,386
+1,086
| +362% | +$12.5K | ﹤0.01% | 4566 |
|
|
2019
Q1 | $4K | Buy |
+300
| New | +$4K | ﹤0.01% | 4732 |
|